US-based Eleanor Health’s $30 million series D investment round was led by General Catalyst.
Health startup Eleanor Health has raised $30 million in funding. The company’s $30 million Series D investment round was led by General Catalyst. US-based Eleanor Health’s investment round included Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.
The company announced that it will use the new investment to scale its model of care for substance use disorder.
Founded in 2019 by Corbin Petro, David Whelan, Nzinga Harrison, Srishti Mirchandani and Trevor Price, Eleanor Health provides outpatient services for adults with substance use disorders. The company takes a holistic approach to tackling addiction. This is because Eleanor Health treats addiction not only as a physical disease, but also as a complex condition with mental and social aspects. Therefore, the treatment process focuses on all areas of individuals’ lives.
The company uses medicines that play an important role in addiction treatment. Medications such as Suboxone and Vivitrol are administered to alleviate withdrawal symptoms and control addiction.
Eleanor Health offers professional psychiatric services and individual or group therapies to support individuals’ mental health. This helps individuals cope with their emotional and psychological problems. The company works with peer coaches who can support individuals in their recovery process. These coaches help to increase patients’ motivation by sharing their personal experiences and providing a supportive environment.
